Select Medical (NYSE:SEM) Shares Cross Above 200 Day Moving Average – What’s Next?

Select Medical Holdings Corporation (NYSE:SEM)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $13.88 and traded as high as $15.30. Select Medical shares last traded at $15.1670, with a volume of 495,325 shares traded.

Analyst Ratings Changes

SEM has been the topic of several research analyst reports. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Mizuho set a $17.00 price target on Select Medical in a research report on Monday, November 3rd. Benchmark restated a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday. Finally, Royal Bank Of Canada raised their target price on shares of Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $17.80.

Select Medical Stock Performance

The business has a 50-day moving average of $14.91 and a two-hundred day moving average of $13.88. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.09 and a quick ratio of 1.09. The company has a market cap of $1.88 billion, a P/E ratio of 17.64, a P/E/G ratio of 0.53 and a beta of 1.26.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 30th. The health services provider reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the company posted $0.43 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. On average, sell-side analysts predict that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th were paid a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.6%. The ex-dividend date was Wednesday, November 12th. Select Medical’s dividend payout ratio (DPR) is 29.07%.

Institutional Trading of Select Medical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada boosted its position in shares of Select Medical by 8.5% in the 1st quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider’s stock worth $1,599,000 after purchasing an additional 7,502 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Select Medical by 96.6% in the first quarter. AQR Capital Management LLC now owns 33,894 shares of the health services provider’s stock worth $566,000 after acquiring an additional 16,656 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Select Medical by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock worth $1,075,000 after acquiring an additional 2,809 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Select Medical during the first quarter valued at about $220,000. Finally, Goldman Sachs Group Inc. raised its position in shares of Select Medical by 25.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider’s stock valued at $12,169,000 after purchasing an additional 147,183 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.